Abstract
Although outcomes for children with cancer have significantly improved over the past 40 years, there has been little progress in the treatment of some pediatric cancers, particularly when advanced. Additionally, clinical trial options and availability are often insufficient. Improved genomic and immunologic understanding of pediatric cancers, combined with innovative clinical trial designs, may provide an enhanced opportunity to study childhood cancers. Master protocols, which incorporate the use of precision medicine approaches, coupled with the ability to quickly assess the safety and effectiveness of new therapies, have the potential to accelerate early-phase clinical testing of novel therapeutics and which may result in more rapid approval of new drugs for children with cancer. Designing and conducting master protocols for children requires addressing similar principles and requirements as traditional adult oncology trials, but there are also unique considerations for master protocols conducted in children with cancer. The purpose of this paper is to define the key challenges and opportunities associated with this approach in order to ensure that master protocols can be adapted to benefit children and adolescents and ensure...Continue Reading
References
Mar 1, 1989·Controlled Clinical Trials·R Simon
Jun 8, 2006·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Lynn W KitchenDonald R Skillman
Jun 29, 2011·Nature Reviews. Clinical Oncology·Ching-Hon PuiAlberto S Pappo
Jun 5, 2012·Acta Neuropathologica·Dong-Anh Khuong-QuangCynthia Hawkins
Apr 17, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Stefan SleijferLillian L Siu
Jun 19, 2013·Nature·Michael S LawrenceGad Getz
Aug 16, 2014·JAMA Internal Medicine·Sidney M Wolfe
Dec 2, 2014·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Gilles VassalHeinz Zwierzina
Feb 15, 2015·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Roy S HerbstVassiliki A Papadimitrakopoulou
Jul 17, 2015·Histopathology·Kongsak LoharamtaweethongChanyoot Bandidwattanawong
Sep 2, 2015·JAMA : the Journal of the American Medical Association·Rajen J ModyArul M Chinnaiyan
Oct 5, 2015·Seminars in Oncology·Mary W Redman, Carmen J Allegra
Nov 1, 2016·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Meredith K ChukGregory H Reaman
Dec 20, 2016·American Journal of Medical Genetics. Part a
Jan 6, 2017·CA: a Cancer Journal for Clinicians·Rebecca L SiegelAhmedin Jemal
Feb 2, 2017·Journal of Hepatocellular Carcinoma·Irene Schmid, Dietrich von Schweinitz
Feb 9, 2017·Pharmacology & Therapeutics·Yekaterina B KhotskayaDavid S Hong
Jul 6, 2017·The New England Journal of Medicine·Janet Woodcock, Lisa M LaVange
Oct 3, 2017·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Lia GoreGregory Reaman
Citations
Dec 4, 2019·Current Opinion in Pediatrics·Kevin CampbellSteven G DuBois
Jun 17, 2020·Pharmaceutical Statistics·Jingjing YeRajeshwari Sridhara
Jun 2, 2020·Frontiers in Pharmacology·Anne SmitsKarel Allegaert
Oct 13, 2020·The Journal of Pediatric Pharmacology and Therapeutics : JPPT : the Official Journal of PPAG·Gilbert J Burckart, Clara Kim
Jul 25, 2019·Contemporary Clinical Trials Communications·Ellie G SidenEdward J Mills
Sep 29, 2019·Pharmacological Reviews·Peter J Houghton, Raushan T Kurmasheva
Jul 6, 2020·Clinical Therapeutics·Elias Laurin MeyerFranz König
May 1, 2021·Journal of Clinical Medicine·Samson GhiluPeter J Houghton
Apr 20, 2021·Frontiers in Genetics·Michael J S BeauvaisBartha Maria Knoppers
Jun 11, 2021·JAMA Oncology·Andrea ArfèFlorence Bourgeois
Jun 27, 2021·Paediatric Drugs·Elly BarryIra A Jacobs
Jul 20, 2021·Future Oncology·Ulrik N LassenBernard Avouac
Sep 24, 2021·Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders·Brooke M CurrieJoseph A Johnston